Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Matthew Yurgelun MD

Matthew B. Yurgelun MD

Assistant Professor of Medicine, Harvard Medical School; Director, Dana-Farber Institute Lynch Syndrome Center, Boston, Massachusetts

Dr. Yurgelun is an Assistant Professor of Medicine at Harvard Medical School and Director of the Dana-Farber Cancer Institute’s Lynch Syndrome Center. He is a medical oncologist who specializes in the care and management of individuals with gastrointestinal malignancies, as well as in the diagnosis and management of individuals with various forms of inherited gastrointestinal cancer risk, including Lynch syndrome. His research has focused on personalized Lynch syndrome risk assessment and in the use of multigene panel testing to evaluate individuals with suspected inherited gastrointestinal cancer syndromes.

Disclosures

Dr. Yurgelun reports the following:
  • Janssen Pharmaceuticals – research funding
  • UpToDate – fees for peer-review services

Recent Contributions to PracticeUpdate:

  1. Actionable Findings on Surveillance EGD in Asymptomatic Patients With Lynch Syndrome
  2. Sulindac and Erlotinib for Duodenal Neoplasia in Familial Adenomatous Polyposis

Most Read This Week

Recently Updated